Kymera Therapeutics
KYMR
KYMR
127 hedge funds and large institutions have $2.76B invested in Kymera Therapeutics in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
36% more capital invested
Capital invested by funds: $2.04B → $2.76B (+$723M)
16.73% more ownership
Funds ownership: 67.86% → 84.6% (+17%)
10% more funds holding
Funds holding: 115 → 127 (+12)
Holders
127
Holding in Top 10
6
Calls
$8.82M
Puts
$294K
Top Buyers
| 1 | +$38.1M | |
| 2 | +$22.7M | |
| 3 | +$20.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$12.8M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$11.6M | |
| 3 | -$10.2M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$7.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.3M |